We examined whether miR-202-3p inhibitor or mimic could be transferred from cancer cells to the brain endothelium and whether miR-202-3p could directly target the 3’UTR of ZO-1, ß-catenin and claudin-5 mRNAs. The gene discussed is CLDN5; the disease is cancer.